Show simple item record

dc.contributor.authorWalsh, Naomi
dc.contributor.authorLarkin, AnneMarie
dc.contributor.authorSwan, Niall
dc.contributor.authorConlon, Kevin
dc.contributor.authorDowling, Paul
dc.contributor.authorMcDermott, Ray
dc.contributor.authorClynes, Martin
dc.date.accessioned2012-11-13T09:28:16Z
dc.date.available2012-11-13T09:28:16Z
dc.date.issued2011-07-28
dc.identifier.citationRNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation. 2011, 306 (2):180-9 Cancer Lett.en_GB
dc.identifier.issn1872-7980
dc.identifier.pmid21470770
dc.identifier.doi10.1016/j.canlet.2011.03.004
dc.identifier.urihttp://hdl.handle.net/10147/251936
dc.description.abstractWe previously identified Hop as over expressed in invasive pancreatic cancer cell lines and malignant tissues of pancreatic cancer patients, suggesting an important role for Hop in the biology of invasive pancreatic cancer. Hop is a co-chaperone protein that binds to both Hsp70/Hsp90. We hypothesised that by targeting Hop, signalling pathways modulating invasion and client protein stabilisation involving Hsp90-dependent complexes may be altered. In this study, we show that Hop knockdown by small interfering (si)RNA reduces the invasion of pancreatic cancer cells, resulting in decreased expression of the downstream target gene, matrix metalloproteinases-2 (MMP-2). Hop in conditioned media co-immunoprecipitates with MMP-2, implicating a possible extracellular function for Hop. Knockdown of Hop expression also reduced expression levels of Hsp90 client proteins, HER2, Bcr-Abl, c-MET and v-Src. Furthermore, Hop is strongly expressed in high grade PanINs compared to lower PanIN grades, displaying differential localisation in invasive ductal pancreatic cancer, indicating that the localisation of Hop is an important factor in pancreatic tumours. Our data suggests that the attenuation of Hop expression inactivates key signal transduction proteins which may decrease the invasiveness of pancreatic cancer cells possibly through the modulation of Hsp90 activity. Therefore, targeting Hop in pancreatic cancer may constitute a viable strategy for targeted cancer therapy.
dc.language.isoenen
dc.publisherCancer lettersen_GB
dc.rightsArchived with thanks to Cancer lettersen_GB
dc.subject.meshAdenocarcinoma, Mucinous
dc.subject.meshBlotting, Western
dc.subject.meshCarcinoma, Pancreatic Ductal
dc.subject.meshCell Adhesion
dc.subject.meshCell Movement
dc.subject.meshDown-Regulation
dc.subject.meshGene Expression Regulation, Neoplastic
dc.subject.meshHSP70 Heat-Shock Proteins
dc.subject.meshHSP90 Heat-Shock Proteins
dc.subject.meshHeat-Shock Proteins
dc.subject.meshHumans
dc.subject.meshImmunoenzyme Techniques
dc.subject.meshImmunoprecipitation
dc.subject.meshMatrix Metalloproteinase 2
dc.subject.meshMolecular Chaperones
dc.subject.meshNeoplasm Invasiveness
dc.subject.meshPancreatic Neoplasms
dc.subject.meshRNA, Small Interfering
dc.subject.meshTumor Cells, Cultured
dc.titleRNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation.en_GB
dc.typeArticleen
dc.contributor.departmentNational Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland. Naomi.walsh@dcu.ieen_GB
dc.identifier.journalCancer lettersen_GB
dc.description.provinceLeinsteren
html.description.abstractWe previously identified Hop as over expressed in invasive pancreatic cancer cell lines and malignant tissues of pancreatic cancer patients, suggesting an important role for Hop in the biology of invasive pancreatic cancer. Hop is a co-chaperone protein that binds to both Hsp70/Hsp90. We hypothesised that by targeting Hop, signalling pathways modulating invasion and client protein stabilisation involving Hsp90-dependent complexes may be altered. In this study, we show that Hop knockdown by small interfering (si)RNA reduces the invasion of pancreatic cancer cells, resulting in decreased expression of the downstream target gene, matrix metalloproteinases-2 (MMP-2). Hop in conditioned media co-immunoprecipitates with MMP-2, implicating a possible extracellular function for Hop. Knockdown of Hop expression also reduced expression levels of Hsp90 client proteins, HER2, Bcr-Abl, c-MET and v-Src. Furthermore, Hop is strongly expressed in high grade PanINs compared to lower PanIN grades, displaying differential localisation in invasive ductal pancreatic cancer, indicating that the localisation of Hop is an important factor in pancreatic tumours. Our data suggests that the attenuation of Hop expression inactivates key signal transduction proteins which may decrease the invasiveness of pancreatic cancer cells possibly through the modulation of Hsp90 activity. Therefore, targeting Hop in pancreatic cancer may constitute a viable strategy for targeted cancer therapy.


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record